Insider · CIK 0001372932

DP VII ASSOCIATES LP

Reports to the SEC for 11 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001372932

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-11-01	Tobira Therapeutics, Inc.U Disposition from Tender	10% Owner	UDisposition from Tender	−47.6K sh	$28.35	−$1.35M	0
2016-10-12	HINDVyome Holdings, Inc · Series A Preferred StockC Conversion	10% Owner	CConversion	−11.1K sh	—	—	0
2016-10-12	HINDVyome Holdings, IncC Conversion	10% Owner	CConversion	+49.6K sh	—	—	49,570
2016-10-12	HINDVyome Holdings, Inc · Series B Preferred StockC Conversion	10% Owner	CConversion	−20.6K sh	—	—	0
2016-10-12	HINDVyome Holdings, Inc · Series C Preferred StockC Conversion	10% Owner	CConversion	−14.3K sh	—	—	0
2016-05-26	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−5,880 sh	$4.70	−$27.6K	10,328
2016-04-27	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−61 sh	$5.02	−$306.22	16,208
2016-04-25	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−21 sh	$5.20	−$109.2	16,269
2016-04-20	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−76 sh	$5.29	−$402.04	16,290
2016-04-19	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−632 sh	$5.36	−$3,387.52	16,366
2016-04-11	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−75 sh	$5.22	−$391.5	16,998
2016-04-08	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−251 sh	$5.35	−$1,342.85	17,073
2016-04-07	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−475 sh	$5.26	−$2,498.5	17,324
2016-04-06	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−148 sh	$5.22	−$772.56	17,799
2015-08-18	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−202 sh	$7.02	−$1,418.04	17,947
2015-04-16	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−554 sh	$7.07	−$3,916.78	18,149
2015-04-15	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−135 sh	$7.58	−$1,023.3	18,703
2015-04-14	EVOKEvoke Pharma IncS Sale	10% Owner	SSale	−168 sh	$7.78	−$1,307.04	18,838
2014-11-25	EVFMEvofem Biosciences, Inc.C Conversion	10% Owner	CConversion	+46.3K sh	—	—	46,309
2014-11-25	EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−2,827 sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−1,570 sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion	10% Owner	CConversion	−36.9K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−12.6K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−104K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	10% Owner	FTax Payment	−958 sh	$14.00	−$13.4K	46,923
2014-11-25	EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−102K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	10% Owner	FTax Payment	−1,725 sh	$14.00	−$24.2K	48,025
2014-11-25	EVFMEvofem Biosciences, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+2,827 sh	$8.54	+$24.1K	49,750
2014-11-25	EVFMEvofem Biosciences, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1,570 sh	$8.54	+$13.4K	47,881
2014-11-25	EVFMEvofem Biosciences, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1,570 sh	$8.54	+$13.4K	47,879
2014-11-25	EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−2,827 sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc.C Conversion	10% Owner	CConversion	+46.3K sh	—	—	46,311
2014-11-25	EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−102K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion	10% Owner	CConversion	−36.9K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−104K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−12.6K sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	10% Owner	FTax Payment	−1,725 sh	$14.00	−$24.2K	48,023
2014-11-25	EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−1,570 sh	—	—	0
2014-11-25	EVFMEvofem Biosciences, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+2,827 sh	$8.54	+$24.1K	49,748
2014-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	10% Owner	FTax Payment	−958 sh	$14.00	−$13.4K	46,921
2014-03-19	CADENCE PHARMACEUTICALS INCD Disposition to Issuer	10% Owner	DDisposition to Issuer	−50.7K sh	$14.00	−$710K	0
2014-03-17	Achaogen, Inc.Series C Preferred StockC Conversion	10% Owner	CConversion	−15.8K sh	—	—	0
2014-03-17	Achaogen, Inc.Series D Preferred StockC Conversion	10% Owner	CConversion	−7,430 sh	—	—	0
2014-03-17	Achaogen, Inc.C Conversion	10% Owner	CConversion	+33.9K sh	—	—	33,890
2014-03-17	Achaogen, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−10.7K sh	—	—	0
2014-02-12	CADENCE PHARMACEUTICALS INCWarrants to Purchase Common StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−23.3K sh	—	—	0
2014-02-12	CADENCE PHARMACEUTICALS INCF Tax Payment	10% Owner	FTax Payment	−13.1K sh	$14.00	−$183K	50,743
2014-02-12	CADENCE PHARMACEUTICALS INCM Exercise/Conversion	10% Owner	MExercise/Conversion	+23.3K sh	$7.84	+$183K	63,801
2013-11-19	TNDMTANDEM DIABETES CARE INC · Series B Preferred StockC Conversion	10% Owner	CConversion	−6,071 sh	—	—	0
2013-11-19	TNDMTANDEM DIABETES CARE INC · Series C Preferred StockC Conversion	10% Owner	CConversion	−9,378 sh	—	—	0

Recent filings

Accepted (ET)
Nov 34
Tobira Therapeutics, Inc.0000904454-16-001529
SEC(opens sec.gov)
Oct 144
OBALON THERAPEUTICS INC0000904454-16-001502
SEC(opens sec.gov)
May 274
Evoke Pharma Inc0000904454-16-001237
SEC(opens sec.gov)
Apr 274
Evoke Pharma Inc0000904454-16-001190
SEC(opens sec.gov)
Apr 214
Evoke Pharma Inc0000904454-16-001172
SEC(opens sec.gov)
Apr 134
Evoke Pharma Inc0000904454-16-001166
SEC(opens sec.gov)
Apr 84
Evoke Pharma Inc0000904454-16-001156
SEC(opens sec.gov)
Aug 204
Evoke Pharma Inc0000904454-15-000538
SEC(opens sec.gov)
Apr 164
Evoke Pharma Inc0000904454-15-000244
SEC(opens sec.gov)
Dec 104/A
Neothetics, Inc.0000904454-14-000791
SEC(opens sec.gov)

Companies

Address

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE

PRINCETON, NJ, 08542